MediOwl develops InflammAid, a digital health platform that utilizes AI-driven biomarker monitoring to detect inflammatory disease flare-ups in rheumatoid arthritis patients before they become symptomatic. This proactive approach enables timely intervention, reducing the risk of severe health complications and reliance on aggressive treatments.
Funding
Funding not disclosed
Founders
Product
Problem
Rheumatoid arthritis patients often experience inflammation flare-ups that are detected late, leading to further health complications such as reduced mobility, deformities, extreme pain, or psychological stress. Delayed detection can also result in organ and nerve damage, as well as increased reliance on aggressive treatments with side effects like hormonal imbalances and weight loss. The diagnostic process for chronic inflammatory diseases can take 2-3 years, causing prolonged suffering and uncertainty for patients.
Solution
MediOwl's InflammAid is a digital health platform designed for rheumatoid arthritis patients that uses AI-driven biomarker monitoring to detect inflammation flare-ups before they become symptomatic. The platform aims to enable earlier intervention and treatment, reducing the need for aggressive treatments. By continuously monitoring digital health data, InflammAid helps patients, physicians, relatives, and the healthcare system manage chronic inflammatory diseases more effectively. The platform empowers patients to proactively combat flare-ups and seek timely treatment, while also providing physicians with data-driven insights for more efficient patient care.
Target Audience
The primary users are rheumatoid arthritis patients, physicians specializing in rheumatology, and healthcare systems focused on managing chronic inflammatory diseases.
Features
- Continuous monitoring of inflammation levels using digital biomarkers.
- AI-driven detection of inflammation flare-ups before symptoms appear.
- Data-based insights for physicians to improve patient care.
- Mobile application for patients to track and manage their condition.